quadgram

This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

quadgram	frequency
nonalcoholic fatty liver disease	148
in dogs and cats	134
no relationships to disclose	122
patients with chronic hepatitis	109
in the treatment of	109
as a result of	107
in patients with chronic	102
in patients with liver	101
alcoholic fatty liver disease	95
for the treatment of	94
in patients with cirrhosis	92
a l p r	84
j o u r	84
l p r e	84
p r o o	84
n a l p	84
r o o f	84
u r n a	84
o u r n	84
r n a l	84
in the presence of	77
at the time of	76
in the united states	72
patients with severe hepatitis	70
in patients with severe	70
it is important to	68
with chronic hepatitis c	67
with acute liver failure	66
of acute liver failure	66
patients with liver cirrhosis	59
in acute liver failure	58
patients with acute liver	56
in patients with covid	56
on the other hand	55
in patients with acute	55
the aim of this	55
of this study was	54
this study was to	54
in the absence of	54
aim of this study	53
is one of the	53
an important role in	53
with chronic hepatitis b	51
at the end of	49
for the diagnosis of	49
patients with liver disease	48
on the basis of	47
with nonalcoholic fatty liver	45
of chronic hepatitis b	41
of chronic liver disease	41
as well as the	41
one of the most	40
of hepatitis b virus	40
in the development of	40
with chronic liver disease	39
in the pathogenesis of	39
has been shown to	39
is the most common	39
can be used to	39
of nonalcoholic fatty liver	38
may be associated with	38
in fulminant hepatic failure	37
play an important role	37
patients with liver injury	36
patients with chronic liver	35
liver injury in covid	33
of liver injury in	33
patients with nonalcoholic fatty	33
efficacy and safety of	32
in the case of	32
in patients with nonalcoholic	32
patients with cirrhosis and	31
was found to be	31
severe acute respiratory syndrome	31
has been reported to	31
of the portal vein	30
acute liver failure in	29
between the two groups	29
systematic review and meta	29
of the liver in	29
to the development of	28
acute respiratory distress syndrome	28
of patients with liver	28
dogs and cats with	28
upper limit of normal	28
there was no significant	27
donation after cardiac death	27
is considered to be	27
a systematic review and	27
in the diagnosis of	27
in addition to the	27
chronic hepatitis b patients	27
in the present study	27
for the study of	27
for the development of	26
in chronic hepatitis c	26
injury in patients with	26
systemic inflammatory response syndrome	25
patients with hepatitis b	25
the upper limit of	25
patients with liver failure	25
in the patients with	25
cd t cell responses	25
as a consequence of	25
portosystemic shunts in dogs	25
play a role in	25
fibrosis in patients with	25
can be divided into	25
to be associated with	24
plays an important role	24
hepatitis b virus infection	24
are more likely to	24
in the management of	24
at the same time	24
in patients with advanced	24
the aim of the	24
a risk factor for	24
in patients with decompensated	24
with fulminant hepatic failure	24
of patients infected with	24
critically ill patients with	23
the caudal vena cava	23
the most common cause	23
most common cause of	23
of patients with acute	23
derived mesenchymal stem cells	23
a total of patients	23
in critically ill patients	22
in chronic liver disease	22
was significantly higher in	22
chronic hepatitis and cirrhosis	22
studies have shown that	22
in patients with fulminant	22
of patients with covid	22
can be associated with	22
the dog and cat	22
has been suggested that	21
it has been suggested	21
been shown to be	21
the present study was	21
the size of the	21
has been associated with	21
in patients with type	21
acute and chronic liver	21
important role in the	21
have been reported in	21
for acute liver failure	21
the common bile duct	21
dogs with chronic hepatitis	21
in the course of	21
it should be noted	21
liver injury in patients	21
fatty liver disease and	21
in a patient with	21
treatment of chronic hepatitis	21
in the liver and	21
hepatitis b surface antigen	20
with the exception of	20
can be used as	20
in patients with non	20
of the liver and	20
no significant difference in	20
in nonalcoholic fatty liver	20
cats with hepatic lipidosis	20
association for the study	20
important to note that	20
is important to note	20
as well as in	20
of the small intestine	20
may be related to	20
has been reported in	20
there was a significant	20
risk factors for liver	20
acute exacerbation of hepatitis	19
a large number of	19
exacerbation of hepatitis b	19
in the control group	19
at the level of	19
it is difficult to	19
a role in the	19
more likely to be	19
the treatment of liver	19
prevention and treatment of	19
is associated with a	19
the end of the	19
in patients with hepatitis	19
the early stage of	19
characteristics of cases of	19
diagnosis and treatment of	19
an increase in the	19
of hepatic encephalopathy in	18
is similar to that	18
the course of the	18
in the majority of	18
was no significant difference	18
increase the risk of	18
was significantly higher than	18
with the use of	18
mg kg po q	18
in the liver of	18
living donor liver transplantation	18
the severity of liver	18
chronic liver disease and	18
patients with fulminant hepatic	18
of cod liver oil	18
patients with decompensated cirrhosis	18
treatment of liver diseases	18
factors for liver injury	18
of patients with chronic	18
of the liver is	18
at a dose of	18
transjugular intrahepatic portosystemic shunt	17
higher than that in	17
higher than that of	17
in dogs with chronic	17
into the systemic circulation	17
of fulminant hepatic failure	17
a result of the	17
of the present study	17
were found to be	17
in patients with lc	17
of spontaneous bacterial peritonitis	17
for the detection of	17
should be noted that	17
in chronic hepatitis b	17
patients with hepatocellular carcinoma	17
these results suggest that	17
the liver is the	17
study was to evaluate	17
in vitro and in	17
in the early stages	17
liver failure caused by	17
may play a role	17
patients with type diabetes	17
vascular endothelial growth factor	17
is based on the	17
were significantly higher in	17
liver disease in dogs	17
fatty liver disease in	17
by the presence of	17
dose of mg kg	16
was to evaluate the	16
be used as a	16
in the form of	16
in cirrhotic patients with	16
of liver disease in	16
the degree of liver	16
times the upper limit	16
to be the most	16
in patients with alf	16
is thought to be	16
patients with chronic hcv	16
can be considered as	16
in the portal vein	16
is related to the	16
size of the liver	16
during the anhepatic stage	16
in cats with hepatic	16
in the setting of	16
may be caused by	16
divided into two groups	16
can be caused by	16
may be due to	16
cirrhosis and hepatocellular carcinoma	16
and the risk of	16
as a cause of	16
of liver fibrosis in	16
the severity of the	16
kg po q h	16
liver disease in cats	16
during the course of	16
of this study is	16
the efficacy and safety	16
may be useful in	16
in liver transplant recipients	16
the study of the	15
similar to that of	15
increased liver enzyme activity	15
positive chronic hepatitis b	15
acute respiratory syndrome coronavirus	15
is associated with the	15
little is known about	15
clinical characteristics of cases	15
serum hbv dna levels	15
levels in patients with	15
has been described in	15
were more likely to	15
the prevention and treatment	15
in patients with a	15
it has been reported	15
it was reported that	15
vitro and in vivo	15
a small amount of	15
of hepatitis c virus	15
the role of the	15
for the presence of	15
and clinical characteristics of	15
diagnosis and management of	15
in the early stage	15
with the severity of	15
of novel coronavirus pneumonia	15
at increased risk for	15
a wide range of	15
infection in patients with	15
chronic hepatitis c patients	15
and the number of	15
liver disease in the	15
in the dog and	15
epidemiological and clinical characteristics	14
is protected by copyright	14
with the degree of	14
of liver injury was	14
patients with nonalcoholic steatohepatitis	14
acute liver failure is	14
function in patients with	14
have been shown to	14
course of the disease	14
article is protected by	14
and the presence of	14
encephalopathy in patients with	14
the purpose of this	14
hepatitis c virus infection	14
was to investigate the	14
west highland white terriers	14
aim of the study	14
be a result of	14
as soon as possible	14
are shown in table	14
of the gastrointestinal tract	14
is more common in	14
and the development of	14
in the number of	14
on chronic liver failure	14
should be treated with	14
hepatic encephalopathy in patients	14
this article is protected	14
considered to be a	14
in a study of	14
occur as a result	14
of chronic hepatitis c	14
hepatitis b patients with	14
more likely to have	14
a major role in	14
as compared to the	14
congenital portosystemic shunts in	14
to an increase in	14
novel coronavirus pneumonia in	14
survival in patients with	14
peripheral blood mononuclear cells	14
study was designed to	14
canine and feline liver	14
with chronic hcv infection	14
transplantation for acute liver	14
patients with severe liver	14
liver transplantation for acute	14
chronic hepatitis c virus	14
especially in patients with	14
the nature of the	13
for the diagnosis and	13
a randomized controlled trial	13
in severe hepatitis patients	13
length of hospital stay	13
a large amount of	13
management of patients with	13
a significant decrease in	13
in puppies and kittens	13
there were no significant	13
herbal and dietary supplements	13
to the severity of	13
of the most common	13
were included in the	13
for the first time	13
of liver injury and	13
with acute respiratory distress	13
in patients treated with	13
a small number of	13
in the context of	13
for the management of	13
been reported to be	13
an independent risk factor	13
there was no difference	13
coronavirus pneumonia in wuhan	13
may or may not	13
a significant increase in	13
the treatment of hepatic	13
and is associated with	13
seen in patients with	13
of cases of novel	13
this study is to	13
role in the pathogenesis	13
a prospective study of	13
increased in patients with	13
extrahepatic bile duct obstruction	13
the patients with severe	13
the treatment of choice	13
for chronic hepatitis b	13
the time of diagnosis	13
patients were treated with	13
study was to investigate	13
exacerbation of chronic hepatitis	13
in the regulation of	13
should be considered in	13
the risk factors for	13
the serum level of	13
patients undergoing liver transplantation	13
significantly higher than that	13
the study of liver	13
cases of novel coronavirus	13
in up to of	13
treatment of patients with	13
holder for this preprint	12
negative chronic hepatitis b	12
the end of treatment	12
have been reported to	12
in the neonatal foal	12
the underlying cause of	12
in patients with primary	12
have been described in	12
aim of the present	12
copyright holder for this	12
the preprint in perpetuity	12
a central role in	12
with the development of	12
be one of the	12
the majority of patients	12
extrahepatic portosystemic shunts in	12
associated with acute respiratory	12
fatty liver disease a	12
the severity of hepatic	12
can be used for	12
has granted medrxiv a	12
closely related to the	12
for this preprint this	12
preprint this version posted	12
who has granted medrxiv	12
the treatment of acute	12
hepatitis b e antigen	12
granted medrxiv a license	12
of acute and chronic	12
cats with liver disease	12
acute on chronic liver	12
patients with hbv infection	12
disease in dogs and	12
hbv dna copies ml	12
the most commonly used	12
one of the major	12
as well as to	12
patients with hepatitis c	12
cells in the liver	12
of mesenchymal stem cells	12
patients with or without	12
have the potential to	12
a decrease in the	12
the levels of serum	12
of hepatobiliary disease in	12
patients with novel coronavirus	12
are similar to those	12
in patients undergoing liver	12
this version posted june	12
medrxiv a license to	12
a license to display	12
of congenital portosystemic shunts	12
display the preprint in	12
markers of liver injury	12
to display the preprint	12
can be found in	12
a retrospective analysis of	12
a retrospective study of	12
the development of liver	12
the copyright holder for	12
after liver transplantation in	12
of coronavirus disease in	12
molecular adsorbent recirculating system	12
is believed to be	12
is the author funder	12
an important cause of	12
this preprint this version	12
in the critically ill	12
study of liver diseases	12
donation after circulatory death	12
transplantation in patients with	12
and hepatitis c virus	12
license to display the	12
young dogs and cats	12
with hepatitis c virus	12
specific cd t cells	11
performed in patients with	11
cause of chronic hepatitis	11
significantly higher than those	11
a is the author	11
in the formation of	11
as a risk factor	11
study was to determine	11
in patients with alcoholic	11
portosystemic shunting in dogs	11
resistant chronic hepatitis b	11
license it is made	11
in the process of	11
hbeag negative chronic hepatitis	11
an increased risk of	11
at the university of	11
is made available under	11
the treatment of chronic	11
found in patients with	11
patients infected with novel	11
survival of patients with	11
acute liver injury and	11
onset of clinical signs	11
patients with advanced liver	11
it is made available	11
caused by a novel	11
intestinal small cell lymphoma	11
of critically ill patients	11
in patients with nafld	11
international license it is	11
made available under a	11
the combination treatment of	11
the cause of the	11
are more common in	11
mortality in patients with	11
american association for the	11
have been associated with	11
with a history of	11
of liver transplantation in	11
and chronic liver disease	11
divided into three groups	11
should be performed in	11
expression in cholangiocytes may	11
was reported to be	11
ace expression in cholangiocytes	11
acute liver failure and	11
the incidence of liver	11
clinical characteristics of coronavirus	11
as part of the	11
a dose of mg	11
to the formation of	11
graft and patient survival	11
in a variety of	11
available under a is	11
proportion of patients with	11
with liver cirrhosis and	11
may be used to	11
with severe liver disease	11
with novel coronavirus in	11
has also been reported	11
abnormal liver function tests	11
does not appear to	11
can be seen in	11
in the pathophysiology of	11
that the incidence of	11
features of patients infected	11
that the levels of	11
coronavirus disease in china	11
for the prevention of	11
signs of abdominal pain	11
novel coronavirus in wuhan	11
partial pressure of oxygen	11
significant difference in the	11
characteristics of coronavirus disease	11
has been reported that	11
the development of hepatic	11
the portal vein and	11
of the presence of	11
remains to be determined	11
with hepatitis b virus	11
lopinavir ritonavir and arbidol	11
a significant reduction in	11
acute exacerbation of chronic	11
as well as a	11
serum bile acid concentrations	11
clinical features of patients	11
of hepatic stellate cells	11
in a group of	11
of the study was	11
infected with novel coronavirus	11
of the dog and	11
it is possible to	11
under a is the	11
infectious diseases of the	11
evaluation of the liver	11
incidence of liver injury	11
are at increased risk	10
middle east respiratory syndrome	10
were randomly divided into	10
patients with portal hypertension	10
in the liver tissue	10
investigate the effect of	10
plays a central role	10
it has been shown	10
are the most common	10
hepatitis b and c	10
if the patient is	10
specific cd t cell	10
the development of hcc	10
the innate immune system	10
is caused by a	10
serum hepatic enzyme activities	10
in a cat with	10
to mg kg day	10
outcomes in patients with	10
hepatic venous pressure gradient	10
role in the development	10
in the two groups	10
the treatment of patients	10
to be caused by	10
considered to be the	10
cd t cells in	10
is involved in the	10
patients who did not	10
of patients with cirrhosis	10
reduce the risk of	10
in patients with chb	10
in dogs with hepatic	10
patients with severe covid	10
of canine and feline	10
arterial partial pressure of	10
common in patients with	10
and the effect of	10
is more likely to	10
dogs with congenital portosystemic	10
patients with and without	10
may cause liver damage	10
had no effect on	10
patients with decompensated liver	10
function of the liver	10
of liver failure in	10
after cardiac death donors	10
in the peripheral blood	10
care of patients with	10
used in the treatment	10
a review of the	10
been reported in cats	10
our aim was to	10
the mean age of	10
food and drug administration	10
the development of the	10
in young dogs and	10
in an attempt to	10
no significant differences in	10
of the bile ducts	10
the clinical signs of	10
alt and ast levels	10
significantly higher in the	10
death in patients with	10
to confirm the diagnosis	10
with advanced liver disease	10
have been identified in	10
acute liver failure acute	10
small intestinal bacterial overgrowth	10
was associated with a	10
ill patients with covid	10
of the disease and	10
and risk factors for	10
is the treatment of	10
severity of liver disease	10
higher than those in	10
diseases of the dog	10
associated with a high	10
were divided into three	10
were no significant differences	10
by a novel coronavirus	10
the presence of a	10
liver fibrosis in patients	10
the liver has a	10
failure acute liver failure	10
in cholangiocytes may cause	10
of chronic hbv infection	10
cholangiocytes may cause liver	10
be caused by a	10
network consists of proteins	10
were significantly higher than	10
liver transplantation in the	10
pathological findings of covid	10
present study was to	10
the total number of	10
be at increased risk	10
to evaluate the efficacy	10
in the assessment of	10
capacity of the liver	10
a high mortality rate	10
be associated with the	10
excessive activation of coagulation	10
in a series of	10
that in patients with	10
a wide variety of	10
in patients with hepatic	10
chronic liver disease in	10
of patients with severe	10
the main cause of	10
increased serum alt activity	10
chronic hepatitis b and	10
with inflammatory bowel disease	10
specific ace expression in	10
of the role of	10
are associated with the	10
in one study of	10
should be taken to	10
are considered to be	10
the basis of the	10
be related to the	10
cause liver damage after	10
be considered in the	10
the effect of the	10
independent risk factors for	10
is associated with increased	10
with chronic liver failure	10
independent risk factor for	10
with fulminant liver failure	10
liver failure acute liver	10
is known about the	10
to the presence of	10
definitive diagnosis is made	10
the proportion of patients	9
role of the liver	9
the expression of tlr	9
liver failure due to	9
liver disease and liver	9
the intensive care unit	9
the length of the	9
of nonalcoholic steatohepatitis in	9
regeneration after partial hepatectomy	9
one of the following	9
with or without liver	9
the study was to	9
diagnosis of hepatobiliary disease	9
is characterized by the	9
the surface of the	9
the majority of cases	9
of acute liver injury	9
this study was designed	9
in the prevention of	9
the beginning of the	9
should not be used	9
and quality of life	9
and the use of	9
hepatitis in doberman pinschers	9
chronic hepatitis c and	9
in combination with ribavirin	9
of this study were	9
of chronic liver diseases	9
chronic hepatitis in dogs	9
a crucial role in	9
for liver injury in	9
the pooled risk of	9
of minimal hepatic encephalopathy	9
with chronic hepatitis and	9
and in patients with	9
purpose of this study	9
may be beneficial in	9
the pathogenesis of liver	9
infected with hcv genotype	9
of the degree of	9
deterioration of liver function	9
related to the severity	9
with an increase in	9
which is associated with	9
in the small intestine	9
with clinical signs of	9
lower than that of	9
should be performed to	9
by the administration of	9
was defined as the	9
of egf transgenic mice	9
metabolized in the liver	9
blood ketone body ratio	9
to a variety of	9
in dogs with congenital	9
ivc and portal vein	9
the american association for	9
disease in patients with	9
hospitalized patients with novel	9
patients with coronavirus disease	9
increases in alt activity	9
the liver can be	9
and nonalcoholic fatty liver	9
and chronic liver failure	9
treatment of hepatic encephalopathy	9
is reported to be	9
of liver damage in	9
on the surface of	9
plays a major role	9
and the degree of	9
the time of the	9
can be classified as	9
of hepatitis b and	9
risk factors associated with	9
cirrhosis of the liver	9
cod liver oil for	9
liver cirrhosis and hepatocellular	9
the diagnosis and treatment	9
study of the liver	9
with a high mortality	9
was not associated with	9
are not specific for	9
these data suggest that	9
in one of the	9
in contrast to the	9
patients with advanced cirrhosis	9
a higher risk of	9
occur in patients with	9
the relationship between the	9
higher in patients with	9
has been shown that	9
increases in serum alt	9
been reported to have	9
was to determine the	9
the central nervous system	9
associated with an increased	9
the diagnosis of hps	9
significantly in patients with	9
are involved in the	9
ischemia and reperfusion injury	9
increases the risk of	9
in serum alt activity	9
liver sinusoidal endothelial cells	9
the most common clinical	9
in those patients with	9
in the normal range	9
and a decrease in	9
reduce the incidence of	9
for fulminant hepatic failure	9
over a period of	9
on the use of	9
of traditional chinese medicine	9
among the three groups	9
of portosystemic shunting in	9
fulminant hepatic failure in	9
sarcopenia in lc patients	9
induced liver injury in	9
in a mouse model	9
studies are needed to	9
during orthotopic liver transplantation	9
at risk of developing	9
a mouse model of	9
liver failure patients with	9
for the prevention and	9
management of acute liver	9
be considered as a	9
the protein expressions of	9
the formation of the	9
to investigate the effect	9
the prognosis of patients	9
is likely to be	9
as the cause of	9
and spontaneous bacterial peritonitis	9
pathogenic human coronavirus infections	9
presence or absence of	9
the use of a	9
the results indicate that	9
must be differentiated from	8
it is concluded that	8
therapy in patients with	8
a significant number of	8
response in patients with	8
should be ruled out	8
as one of the	8
in patients with hepatocellular	8
in hospitalized patients with	8
of the common bile	8
in order to determine	8
significantly increased in iri	8
significantly increased in patients	8
dynamic changes in liver	8
nafld and t dm	8
may be helpful in	8
should be based on	8
of the relationship between	8
enrolled in this study	8
may occur as a	8
of hospitalized patients with	8
of the biliary tract	8
history of liver disease	8
has not yet been	8
characteristics of hospitalized patients	8
were enrolled in this	8
the majority of the	8
in cats with liver	8
were not significantly different	8
should be given to	8
critically ill and non	8
sensitivity and specificity for	8
cod liver oil and	8
related quality of life	8
a reduction in the	8
has been used for	8
were included in this	8
it has also been	8
associated with portal hypertension	8
with increased risk of	8
the result of a	8
with chronic liver diseases	8
in patients with nash	8
as a part of	8
is strongly associated with	8
did not have a	8
are at risk of	8
with cirrhosis and spontaneous	8
development of hepatocellular carcinoma	8
sensitivity and specificity of	8
liver injury during highly	8
of genes involved in	8
diagnosis of canine and	8
in the short term	8
for patients with severe	8
transplantation using donation after	8
patients were divided into	8
is part of the	8
is usually associated with	8
to mg kg po	8
chronic hepatitis b virus	8
cirrhosis and spontaneous bacterial	8
in the metabolism of	8
an important part of	8
from a single center	8
in the general population	8
differences between the two	8
aims of this study	8
occurs in patients with	8
a group of patients	8
in patients with genotype	8
in more than of	8
liver transplantation in patients	8
have a role in	8
an intensive care unit	8
disease in the cat	8
is associated with high	8
the portal vein is	8
at higher risk for	8
if the cat is	8
increased serum alp activity	8
in the progression of	8
may be involved in	8
it is believed that	8
into the portal vein	8
flavored cod liver oil	8
weight body weight ratio	8
in iri mito than	8
in patients with end	8
diagnosis is made by	8
failure fulminant hepatic failure	8
the mean number of	8
is closely related to	8
west highland white terrier	8
the quantity of hepatocellular	8
he in patients with	8
the liver may be	8
of acute exacerbation of	8
the end of therapy	8
injury during highly pathogenic	8
tumours of egf transgenic	8
infection in a dog	8
report of three cases	8
more likely to occur	8
in patients with he	8
acute hepatitis and necrosis	8
it is appropriate to	8
has the potential to	8
to play a role	8
between markers of liver	8
the wall of the	8
can lead to the	8
highly pathogenic human coronavirus	8
were not associated with	8
significant differences in the	8
in some patients with	8
associated viral hepatitis caused	8
been reported to cause	8
likely to occur in	8
correlation was found between	8
has been used in	8
clinical characteristics of hospitalized	8
acute or chronic liver	8
for the patients with	8
metabolized by the liver	8
of the liver to	8
in cats with chronic	8
associated with increased risk	8
treatment of lopinavir ritonavir	8
than that in the	8
should be considered as	8
by vitamin k absence	8
a pivotal role in	8
during the study period	8
cd regulatory t cells	8
of human hepatocellular carcinoma	8
liver disease and cirrhosis	8
of liver disease and	8
of lopinavir ritonavir and	8
of reactive oxygen species	8
the serum levels of	8
liver failure in the	8
in the bone marrow	8
viral hepatitis caused by	8
more common in cats	8
included in this study	8
be used as an	8
the liver in dogs	8
during highly pathogenic human	8
hepatitis caused by a	8
has not been reported	8
associated with the development	8
activated partial thromboplastin time	8
and abnormal liver function	8
liver damage in patients	8
the results of the	8
hepatitis b and hepatitis	8
in hepatic stellate cells	8
it is possible that	8
liver fat content in	8
type patients with hepatitis	8
common in cats than	8
may need to be	8
it was found that	8
can also be seen	8
the aims of this	8
the level of the	8
with type diabetes mellitus	8
as a marker of	8
of the development of	8
right upper quadrant pain	8
may be difficult to	8
the degree of hepatic	8
is a result of	8
cd cd regulatory t	8
combination treatment of lopinavir	8
before and after the	8
in the operating room	8
the gold standard for	8
for a minimum of	8
the space of disse	8
chronic hepatitis b in	8
of the most important	8
on the degree of	8
of liver biopsy specimens	8
may be seen in	8
of patients with a	8
that there is a	8
patients with acute and	8
in patients with hcv	8
alcoholic fatty liver diseases	8
with varying degrees of	8
of transforming growth factor	8
of the patients with	8
a high level of	8
liver transplantation for fulminant	8
safety and efficacy of	8
to play an important	8
may be required to	8
in accordance with the	8
the diagnosis of acute	7
of the liver function	7
hbv dna levels were	7
one of the factors	7
is the most important	7
and shortness of breath	7
for the prediction of	7
iri than in sc	7
hepatopulmonary syndrome and portopulmonary	7
and the role of	7
the model for end	7
functions of the liver	7
liver failure can be	7
and should be considered	7
in the united kingdom	7
severity of liver injury	7
tumors of the liver	7
by polymerase chain reaction	7
in the liver is	7
on the development of	7
iri mito than in	7
feline pancreatic lipase immunoreactivity	7
of the patients had	7
treatment of choice for	7
cells as well as	7
number of patients with	7
with an increased risk	7
the ivc and portal	7
of proteins including significantly	7
up to of patients	7
failure in patients with	7
in patients with mild	7
in patients with portal	7
enrolled in the study	7
we have developed a	7
multivariate analysis showed that	7
cats than in dogs	7
in the prevention and	7
number of concomitant medications	7
should be evaluated for	7
a week for weeks	7
the critically ill group	7
the diagnostic criteria for	7
can be used in	7
damage in patients with	7
indications for liver transplantation	7
liver failure is a	7
more than of the	7
physical examination findings are	7
in patients with different	7
may be present in	7
in group a and	7
was higher than that	7
by a number of	7
for patients with acute	7
the underlying disease process	7
g kg body weight	7
by a variety of	7
infection after liver transplantation	7
hepatobiliary disease in dogs	7
in a dog disseminated	7
the portal venous blood	7
on the presence of	7
cirrhosis and portal hypertension	7
t cell responses were	7
cause of acute liver	7
hepatic stellate cell activation	7
this work was supported	7
used for the treatment	7
group of patients with	7
in the face of	7
the use of these	7
may be necessary to	7
has been suggested to	7
alt and alp activity	7
in a rat model	7
the first year of	7
shunts in dogs and	7
of patients with hps	7
in cats than in	7
of portosystemic shunts in	7
transforming growth factor beta	7
should be considered when	7
and the incidence of	7
the authors declare that	7
may be used for	7
hepatorenal syndrome in cirrhosis	7
for treatment of liver	7
the absence of a	7
b and hepatitis c	7
with the occurrence of	7
patients awaiting liver transplantation	7
association between markers of	7
associated fatty liver disease	7
be the result of	7
been reported in the	7
of liver failure are	7
were significantly associated with	7
plays a pivotal role	7
more commonly associated with	7
the results showed that	7
in vivo and in	7
to chronic liver disease	7
in the veterinary literature	7
be due to the	7
using donation after cardiac	7
for chronic hepatitis c	7
with liver disease during	7
little cause for concern	7
induced acute liver failure	7
such as those with	7
in sc and iri	7
can be detected in	7
chronic hepatitis c genotype	7
hepatic abscesses in dogs	7
the systemic inflammatory response	7
patients with primary biliary	7
congenital extrahepatic portosystemic shunts	7
the risk of liver	7
was significantly associated with	7
to the degree of	7
study was conducted in	7
dogs with hepatic disease	7
not appear to be	7
and tumor necrosis factor	7
dogs with liver disease	7
for at least months	7
is determined by the	7
the dynamic changes of	7
results of a prospective	7
in the late stages	7
in patients with hbv	7
of disseminated intravascular coagulation	7
if the patient has	7
this study were to	7
no significant differences between	7
than in sc and	7
liver disease can be	7
the most common causes	7
clamping of the ivc	7
in chronic hbv infection	7
to be effective in	7
of the underlying cause	7
risk of disease progression	7
is positively correlated with	7
in liver transplant patients	7
in more detail in	7
the expression of the	7
transplantation for fulminant hepatic	7
authors declare that they	7
in of the patients	7
as a screening test	7
or without liver injury	7
complications of liver disease	7
that they have no	7
been described in cats	7
the development of severe	7
have been used to	7
diseases of the liver	7
higher in severe covid	7
of alt and ast	7
used in combination with	7
the mononuclear phagocyte system	7
the rest of the	7
the importance of the	7
the presence of liver	7
were found to have	7
as high as in	7
concentrations in the diagnosis	7
the intrahepatic bile ducts	7
disease control and prevention	7
pegylated interferon and ribavirin	7
a retrospective review of	7
treatment of liver failure	7
it is recommended to	7
with the risk of	7
liver transplantation in children	7
after weeks of therapy	7
from the gi tract	7
is responsible for the	7
patients were included in	7
proteins including significantly regulated	7
of liver function in	7
were divided into two	7
patients with acute hepatitis	7
severity of clinical signs	7
there is no significant	7
the management of acute	7
of serum liver enzymes	7
with a variety of	7
a linear foreign body	7
the treatment of hcc	7
cd t cells were	7
liver is an important	7
for a long time	7
hepatitis and cirrhosis in	7
which may lead to	7
and acute liver failure	7
the expression level of	7
liver transplantation is the	7
the expression levels of	7
to rule out other	7
including significantly regulated proteins	7
via the portal vein	7
may lead to the	7
our results suggest that	7
for nonalcoholic fatty liver	7
in patients with pre	7
sc and iri mito	7
liver disease in patients	7
patients with severe acute	7
of hepatocellular carcinoma in	7
infections in patients with	7
a high incidence of	7
the early stages of	7
acute liver failure with	7
in a timely manner	7
liver regeneration after partial	7
the presence or absence	7
declare that they have	7
fibrosis in chronic hepatitis	7
extrahepatic biliary tract obstruction	7
were randomized to receive	7
clinical features of covid	7
the most common liver	7
are summarized in table	7
a majority of patients	7
significant differences between the	7
outcomes of patients with	7
liver injury in the	7
severity of hepatic encephalopathy	7
east respiratory syndrome coronavirus	7
vivo and in vitro	7
had a history of	7
and the severity of	7
studies have demonstrated that	7
findings in dogs with	7
compared with the control	7
a critical role in	7
liver disease during the	7
consists of proteins including	7
and treatment of liver	7
ischemia reperfusion injury in	7
in an animal model	7
a mortality rate of	7
to the patients with	7
there is no evidence	7
with small cell lymphoma	7
used to detect the	7
with the progression of	7
the hepatitis b virus	7
the innate immune response	7
of acute liver disease	7
is the most commonly	7
infected pneumonia in wuhan	7
and cats with acute	7
associated with liver disease	7
a vital role in	7
patients with viral hepatitis	7
in iri than in	7
were observed in the	7
progression of the disease	7
is an important cause	7
there is no specific	7
the clinical efficacy of	7
the first weeks of	7
in of cats with	7
activation of hepatic stellate	7
group was higher than	7
dna log copies ml	7
was no difference in	7
in tumours of egf	7
existing chronic liver disease	7
branched chain amino acids	7
of patients in the	7
syndrome and portopulmonary hypertension	7
can be difficult to	7
an essential role in	7
cause of chronic liver	7
in patients with ascites	7
attention should be paid	7
white blood cell count	7
dogs with chronic liver	7
reported outcome data on	7
total of patients were	7
there was no evidence	7
a result of a	7
have a history of	7
bile acid concentrations in	7
for liver transplantation in	7
was the most common	7
the liver is an	7
cod liver oil was	7
of the immune system	7
a common cause of	7
is the result of	7
in a dog with	7
has not been fully	7
the severity of covid	7
liver failure induced by	7
be found in patients	7
because of the high	7
for more than years	7
with decompensated liver cirrhosis	7
risk of hepatocellular carcinoma	7
of liver failure and	7
hepatitis b virus in	7
the development of an	6
prognosis of patients with	6
to study the effect	6
evidence of hepatic dysfunction	6
investigate the effects of	6
histological diagnosis of canine	6
a definitive diagnosis of	6
had at least one	6
in the production of	6
the lower esophageal sphincter	6
with low cardiac output	6
not be able to	6
major role in the	6
liver injury and mortality	6
a descriptive study clinical	6
of dogs and cats	6
with chronic hbv infection	6
be a risk factor	6
can lead to a	6
between patients with or	6
pcr and western blot	6
of the gallbladder wall	6
treatment of nonalcoholic steatohepatitis	6
occurrence and development of	6
clinical characteristics and outcomes	6
injury was defined as	6
hepatitis e virus infection	6
end stage liver disease	6
there were significant differences	6
patients with low cardiac	6
considered as one of	6
was approved by the	6
patients with evidence of	6
with severe hepatitis are	6
most common causes of	6
claims in published maps	6
than or equal to	6
of the liver can	6
the lowest effective dose	6
has been proposed as	6
associated liver injury is	6
as a predictor of	6
a total of n	6
t cells in the	6
is important to remember	6
in the liver are	6
end of treatment and	6
in serum alp activity	6
are shown in the	6
the novel coronavirus disease	6
treatment of acute liver	6
liver transplant providers during	6
may be one of	6
evaluate the effect of	6
lower esophageal sphincter tone	6
on the role of	6
majority of patients with	6
the mean level of	6
are at risk for	6
the pathogenesis of severe	6
is the most frequent	6
treatment of minimal hepatic	6
standards for clinical and	6
contribute to the development	6
one of the important	6
for patients with liver	6
discussed in more detail	6
the severity of steatosis	6
the molecular adsorbent recirculating	6
into the peritoneal cavity	6
more common in patients	6
in hepatitis c virus	6
with primary biliary cirrhosis	6
found to be more	6
in hcv infected patients	6
in a retrospective study	6
after cardiac death liver	6
present with signs of	6
an analysis of the	6
hepatitis c virus genotypes	6
were significant differences in	6
liver function in the	6
the stage of fibrosis	6
to the intensive care	6
in patients with child	6
has been suggested as	6
mesenchymal stem cells in	6
and cd t cells	6
in hbeag negative chronic	6
patients infected with genotype	6
may not be the	6
the diagnosis of hepatobiliary	6
a key role in	6
liver and kidney function	6
may have a role	6
after intravenous injection of	6
inducible nitric oxide synthase	6
were significantly increased in	6
study of cats with	6
cats with inflammatory bowel	6
outcome of liver transplantation	6
of the stomach and	6
hepatic lipidosis in cats	6
may contribute to the	6
diagnosis and therapy of	6
identification and characterization of	6
was used to detect	6
activated hepatic stellate cells	6
may develop secondary to	6
and liver disease in	6
with cod liver oil	6
patients infected with sars	6
in the initiation of	6
patients with advanced hcc	6
the rate of hbsag	6
was associated with the	6
with the stage of	6
in patients infected with	6
t and g a	6
of to mg kg	6
to that of the	6
the inferior vena cava	6
appear to be at	6
pressure in the portal	6
an animal model of	6
in view of the	6
chronic hepatitis b or	6
more than half of	6
levels of alanine aminotransferase	6
in the evaluation of	6
log copies ml at	6
development of portal hypertension	6
of extrahepatic biliary obstruction	6
is more sensitive than	6
it is not clear	6
of the innate immune	6
children living in the	6
patient with liver failure	6
upper limit of the	6
the survival of patients	6
it is very important	6
there was no statistically	6
with intestinal small cell	6
the progression of fibrosis	6
phase ii clinical trial	6
more sensitive than the	6
in dogs treated with	6
has been attributed to	6
ventilation blood flow ratio	6
may also contribute to	6
produced by the liver	6
for a total of	6
were compared with those	6
patients with severe and	6
with acute and chronic	6
it was possible to	6
has been used to	6
of a patient with	6
it is also a	6
the major cause of	6
in the meld group	6
springer nature remains neutral	6
cd t cells was	6
of kupffer cells in	6
significantly different between the	6
patients at risk of	6
is similar to the	6
as the result of	6
been shown to have	6
for early detection of	6
patients in both groups	6
to a reduction in	6
regard to jurisdictional claims	6
on the management of	6
to the lowest effective	6
be explained by the	6
patients were randomized to	6
clinical and histological diagnosis	6
appears to be the	6
used to assess the	6
on the effect of	6
diagnosis and prognosis of	6
within the normal range	6
acute liver failure at	6
plasma separation and adsorption	6
proteins of which are	6
pathogenesis of hepatic encephalopathy	6
disease during the covid	6
is a common finding	6
treatment for patients with	6
in patients suffering from	6
findings in dogs and	6
in the differential diagnosis	6
is commonly used in	6
of advanced fibrosis in	6
beginning of the therapy	6
patients with fulminant hepatitis	6
in liver tissues of	6
in the near future	6
is an important factor	6
is a member of	6
characteristics and mechanism of	6
crucial role in the	6
liver has a large	6
we have shown that	6
of chronic hepatitis in	6
remains neutral with regard	6
undetectable hcv rna at	6
a higher incidence of	6
neutral with regard to	6
the dynamic changes in	6
the clinical characteristics of	6
has been described as	6
led to the development	6
can also lead to	6
or the presence of	6
to investigate the effects	6
study was conducted to	6
in human hepatocellular carcinoma	6
the absence of hepatic	6
mechanism of liver injury	6
acute liver failure due	6
is important to recognize	6
the underlying cause is	6
providers during the covid	6
cause of death in	6
after circulatory death liver	6
part of the diagnostic	6
acute liver failure study	6
infection is associated with	6
was no evidence of	6
congenital portosystemic vascular anomalies	6
of vitamin a and	6
and chronic severe hepatitis	6
of the novel coronavirus	6
and transforming growth factor	6
and cirrhosis in dogs	6
the natural history of	6
did not differ significantly	6
infiltration of the liver	6
with moderate to severe	6
as shown in table	6
infection of the liver	6
of the liver transplant	6
it is associated with	6
and it has been	6
be associated with a	6
in a number of	6
should be paid to	6
jurisdictional claims in published	6
liver injury was related	6
in dogs with liver	6
in the kidney and	6
of hepatic fibrosis and	6
care must be taken	6
type of liver failure	6
that liver injury in	6
patients with fulminant liver	6
in patients that are	6
complete blood cell count	6
but it is not	6
and the ability to	6
in the blood and	6
study clinical characteristics of	6
the clinical course of	6
be involved in the	6
because of the presence	6
may be a result	6
into the abdominal cavity	6
the diagnosis and therapy	6
of liver fibrosis and	6
should be considered if	6
a liver transplant recipient	6
measured before and after	6
it is caused by	6
that can be used	6
of fatty liver disease	6
be used to predict	6
have no conflict of	6
induced liver injury is	6
is characterized by a	6
to the pathogenesis of	6
alpinia officinarum rhizome extract	6
and outcomes of covid	6
the risk of infection	6
as an indicator of	6
the sensitivity of the	6
published maps and institutional	6
based on clinical signs	6
under the condition of	6
a higher rate of	6
mitochondria isolated from virus	6
induced by carbon tetrachloride	6
factors of liver injury	6
induced by vitamin k	6
to a decrease in	6
liver failure study group	6
cases of acute liver	6
and histologic evidence of	6
risk of liver injury	6
in patients with hcc	6
may play an important	6
if there is a	6
injury was related to	6
the mechanism of action	6
the diagnostic accuracy of	6
patients who died of	6
levels were higher in	6
living in the united	6
was used as a	6
clinical signs of liver	6
is a risk factor	6
the presence of portosystemic	6
survival after liver transplantation	6
were independent risk factors	6
should also be considered	6
of the ivc and	6
an important factor in	6
of vitamin a in	6
the united states and	6
as the presence of	6
induced fulminant hepatic failure	6
cd and cd t	6
cats with intestinal small	6
anomalies in the dog	6
different between the two	6
of hbv and hcv	6
less common in cats	6
times a week for	6
of he in patients	6
primary carcinoma of liver	6
diagnosis of liver disease	6
lead to the formation	6
causes of liver disease	6
and are associated with	6
because of the potential	6
associated with a poorer	6
in the cat is	6
a systemic inflammatory response	6
was observed in patients	6
nature remains neutral with	6
damage to the liver	6
higher than those of	6
it is thought to	6
proteins were mapped to	6
with regard to jurisdictional	6
conducted to evaluate the	6
as well as by	6
associated liver disease in	6
the improvement of the	6
was lower than that	6
the liver plays a	6
patients with chronic hbv	6
with severe acute respiratory	6
changes in the liver	6
did not appear to	6
with the presence of	6
and histological diagnosis of	6
the number of concomitant	6
can also result in	6
is not associated with	6
for the synthesis of	6
in the first year	6
with severe hepatitis b	6
of dogs with chronic	6
we found that the	6
believed to be the	6
to the liver in	6
patients with hepatic encephalopathy	6
after orthotopic liver transplantation	6
stages of the disease	6
at the beginning of	6
cells in patients with	6
the presence of an	6
to hepatitis c virus	6
transplant providers during the	6
should be avoided in	6
assessment of liver function	6
be divided into two	6
more than of patients	6
chronic hepatitis in the	6
classification of liver failure	6
with acute hepatitis and	6
and is characterized by	6
no significant difference between	6
risk factors for the	6
for those patients with	6
the world health organization	6
disease is associated with	6
given at a dose	6
in this study we	6
was associated with increased	6
randomized controlled trial of	6
which may be the	6
degree of liver damage	6
the blood glucose level	6
as a source of	6
for treatment of chronic	6
in the use of	6
was no statistically significant	6
to determine whether the	6
of patients with alf	6
and the level of	6
in to of cases	6
develop as a result	6
in the abdominal cavity	6
than those in patients	6
can be treated with	6
will be needed to	6
not associated with clinical	6
factor for the development	6
it is also possible	6
maps and institutional affiliations	6
no difference in the	6
patients with alcoholic liver	6
results suggest that the	6
in a liver transplant	6
of patients with hbv	6
the prepatent period is	6
study was performed in	6
that the expression of	6
mg kg iv q	6
the pathogenesis of hepatic	6
be used to assess	6
of disease regulated proteins	6
used to confirm the	6
it is not known	6
kg iv q h	6
makes it difficult to	6
a t and g	6
liver disease as a	6
in the intestinal tract	6
observed in patients with	6
disease regulated proteins were	6
the sensitivity and specificity	6
with alcoholic liver disease	6
the development of hepatocellular	6
of the urea cycle	6
it is unclear whether	6
of liver function is	6
in a murine model	6
sarcopenia in patients with	6
further studies are needed	6
to jurisdictional claims in	6
liver failure in children	6
patients with advanced fibrosis	6
and mechanism of liver	6
portosystemic shunts in cats	6
in this study were	6
the molecular pathogenesis of	6
compared to the control	6
similar to those of	6
this study was conducted	6
similar to those described	6
work was supported by	6
with congenital portosystemic shunts	6
the liver in the	6
study was to assess	6
increased serum bile acids	6
reader is referred to	6
in dogs with portosystemic	6
with chronic severe hepatitis	6
management of hepatic encephalopathy	6
of patients who underwent	6
it has not been	6
risk factor for the	6
bleeding in patients with	6
in published maps and	6
dysfunction in patients with	6
lower than that in	6
of abdominal pain in	6
during the first weeks	6
than months of age	6
changes in liver function	6
can be achieved by	6
of liver disease is	6
chronic active hepatitis in	6
the stage of disease	6
alone or in combination	5
and without t dm	5
the time of transplantation	5
cellular and molecular mechanisms	5
did not differ between	5
hbc and or anti	5
the guideline for the	5
is believed that the	5
steatosis in patients with	5
invoked by vitamin k	5
of ascites in cats	5
aimed to evaluate the	5
cause of liver failure	5
be considered as an	5
and cats with liver	5
in the peritoneal cavity	5
extrahepatic biliary obstruction in	5
the liver and spleen	5
hepatic blood flow and	5
a significant improvement in	5
of serum alt activity	5
obstruction of the common	5
was shown to be	5
a retrospective cohort study	5
of a series of	5
test for liver disease	5
to the caudal vena	5
mechanisms of liver injury	5
to be related to	5
associated with an increase	5
of the canine and	5
chronic severe hepatitis b	5
in liver tissue was	5
these findings suggest that	5
in orthotopic liver transplantation	5
in patients with normal	5
the occurrence of he	5
risk factor for hcc	5
the proportion of peripheral	5
with acute hepatic failure	5
serum bile acids concentrations	5
of chronic liver failure	5
the most commonly reported	5
chronically infected with hcv	5
due to a lack	5
findings and bleeding complications	5
three times a week	5
within the hepatic parenchyma	5
per kg body weight	5
and ast levels were	5
associated with clinical outcomes	5
are the result of	5
hepatology and liver transplant	5
been suggested to be	5
the liver in patients	5
the risk of developing	5
explore the risk factors	5
tumour specific gene expression	5
hbv dna log copies	5
canine acidophil cell hepatitis	5
the severity of hepatitis	5
outcomes of critically ill	5
a number of reasons	5
has been implicated in	5
an independent predictor of	5
acute hepatic necrosis and	5
is also important to	5
it is known that	5
of acute hepatitis b	5
mrna and protein levels	5
of serum alanine aminotransferase	5
liver injury in non	5
may be at increased	5
were similar in the	5
alkalosis plus metabolic acidosis	5
is very important to	5
in agreement with the	5
the degree of fibrosis	5
be the most common	5
fatty liver disease serum	5
was considered statistically significant	5
can be affected by	5
it is assumed that	5
were risk factors for	5
with regard to the	5
liver disease should be	5
should be further evaluated	5
dogs with hepatic encephalopathy	5
has also been described	5
patients with hepatic failure	5
the prevalence of hcv	5
the mean age was	5
the treatment of non	5
which was associated with	5
to be a result	5
evaluate the efficacy and	5
patients with compensated cirrhosis	5
we observed a significant	5
pcr and western blotting	5
polycystic kidney and liver	5
of hepatic steatosis and	5
liver ischemia reperfusion injury	5
medicine for the treatment	5
the activation of the	5
is shown in figure	5
not correlate with the	5
term efficacy and safety	5
similar to that for	5
proportion of peripheral blood	5
dna levels copies ml	5
play a major role	5
rats were treated with	5
of prognosis in fulminant	5
there is evidence of	5
has a variety of	5
be seen in patients	5
the meld scoring system	5
chronic liver failure is	5
hepatitis and liver failure	5
cohort of patients with	5
hepatitis b or c	5
of the intestinal tract	5
kidney and liver disease	5
acute liver failure the	5
much higher than that	5
of hospital stay and	5
may be an important	5
to be independent of	5
the ethanolic extract of	5
divided into three types	5
it was shown that	5
the course of acute	5
cirrhosis patients with ascites	5
liver failure in patients	5
on acute liver failure	5
which may be a	5
at least in the	5
was higher in the	5
as many as of	5
were compared using the	5
of orthotopic liver transplantation	5
as a complication of	5
was seen in the	5
liver ischemia and reperfusion	5
and protein expression of	5
profile findings and bleeding	5
the pathogenesis of chronic	5
management of severe acute	5
clinical signs associated with	5
time polymerase chain reaction	5
treatment of fulminant hepatic	5
dogs with acute hepatitis	5
university school of medicine	5
of the intestinal mucosa	5
for use in cats	5
total of patients with	5
inflammation and oxidative stress	5
not significantly different from	5
of hepatic steatosis in	5
cases from a single	5
times in clinically ill	5
emergency liver transplantation for	5
reduces the incidence of	5
risk for development of	5
a minimum of months	5
to test the hypothesis	5
nicotinamide adenine dinucleotide phosphate	5
network for organ sharing	5
also be seen in	5
into the caudal vena	5
of the following criteria	5
of cd cd regulatory	5
with congenital portosystemic vascular	5
pediatric acute liver failure	5
can occur as a	5
which may be due	5
on the liver graft	5
study is to evaluate	5
the therapeutic effect of	5
the cat should be	5
proteins induced by vitamin	5
disease secondary to liver	5
evaluating the efficacy of	5
with the number of	5
cause an increase in	5
the occurrence and development	5
was closely related to	5
auxiliary liver transplantation for	5
dogs with portosystemic shunts	5
similar in both groups	5
be responsible for the	5
oxygen delivery and consumption	5
to the use of	5
and hepatorenal syndrome in	5
may be affected by	5
no conflict of interest	5
intestinal bacterial overgrowth in	5
pancreatic disease in the	5
abdominal pain and fever	5
clinical signs of he	5
such as the liver	5
observed that the levels	5
the course of covid	5
with the control group	5
at an early stage	5
in liver transplantation using	5
it is very difficult	5
and there is no	5
number of patients in	5
pneumonia in wuhan clinical	5
mesenchymal stem cells and	5
to be an important	5
for the evaluation of	5
for chronic liver disease	5
there are no specific	5
a dose dependent manner	5
findings from patients with	5
of patients with hcc	5
was found to have	5
a phase ii clinical	5
a history of chronic	5
of the combination of	5
hepatic injury in patients	5
orthotopic liver transplantation in	5
by the fact that	5
mice treated with cc	5
course and outcomes of	5
can also be used	5
than that in patients	5
of peripheral blood tregs	5
caused by a variety	5
development of hepatic encephalopathy	5
in liver failure patients	5
a substantial increase in	5
vitamin a and iu	5
and response to treatment	5
has not been demonstrated	5
can be expected to	5
is a very important	5
of inflammatory bowel disease	5
was conducted to evaluate	5
levels of alt and	5
on survival in patients	5
in hbeag positive patients	5
as well as liver	5
and an increase in	5
liver diseases in patients	5
should be considered for	5
longitudinal association between markers	5
the hepatic energy charge	5
with sensitivity and specificity	5
the development of he	5
a variety of other	5
a member of the	5
cirrhotic patients with ascites	5
the presence of hcv	5
increase in the number	5
should be directed at	5
severity of nonalcoholic fatty	5
within the reference interval	5
study was carried out	5
order to evaluate the	5
patients with normal alt	5
the time of presentation	5
for the assessment of	5
as a bridge to	5
because of reduced hepatic	5
of chronic hepatitis and	5
acute and chronic hepatitis	5
may be the primary	5
is now believed that	5
inflammatory bowel disease and	5
were lower in the	5
invasion and metastasis of	5
epidermal growth factor receptor	5
evaluate the efficacy of	5
a wide spectrum of	5
significantly higher in iri	5
used as an indicator	5
o o f the	5
liver disease due to	5
rats were divided into	5
treatment in patients with	5
the incidence of hps	5
and length of stay	5
paracentesis should be performed	5
in addition to their	5
due to hepatitis b	5
adult respiratory distress syndrome	5
was performed in patients	5
the food and drug	5
direct effect of the	5
confirm the diagnosis of	5
may be beneficial for	5
patients with genotype c	5
the diameter of the	5
among the most important	5
reduce the chance of	5
tested the hypothesis that	5
be given to the	5
retrospective analysis of cases	5
congenital hepatic arteriovenous fistulas	5
liver disease may be	5
serum alp and ggt	5
bile acids as a	5
is well known that	5
due to lack of	5
case of acute liver	5
effective arterial blood volume	5
renal function in patients	5
with a decrease in	5
than in those with	5
hepatic encephalopathy in cirrhosis	5
the clinical manifestations of	5
failure can be divided	5
a higher level of	5
length of stay was	5
are discussed in more	5
blood flow to the	5
it remains to be	5
the beneficial effects of	5
in critically ill and	5
the differential diagnosis of	5
the number of patients	5
risk factors of liver	5
radiological findings from patients	5
or in combination with	5
has proved to be	5
than half of the	5
of the intrahepatic bile	5
significantly lower than that	5
of liver cells and	5
with corona virus disease	5
is an obligate intracellular	5
in patients with minimal	5
mito than in sc	5
appear to be a	5
and in some cases	5
coagulation profile findings and	5
has also been associated	5
the level of th	5
and there was no	5
and clinical outcomes in	5
lc patients with sarcopenia	5
of pancreatitis in cats	5
chronic hepatitis c in	5
injury and mortality in	5
degree of liver injury	5
increases in serum alp	5
in the young dog	5
the canine and feline	5
have not been reported	5
causes of acute liver	5
and virological characteristics of	5
in patients with viral	5
of these patients is	5
patients chronically infected with	5
of free amino acids	5
as part of a	5
characterized by the presence	5
of the effects of	5
in the diagnosis and	5
pulmonary vascular dilatation and	5
for hepatic encephalopathy in	5
be used with caution	5
were males and females	5
does not rule out	5
expression of tlr and	5
the liver in a	5
in west highland white	5
vary depending on the	5
that there was no	5
all over the world	5
may be required in	5
young dog and cat	5
the objectives of this	5
are part of the	5
hepatobiliary disease in the	5
of cases from a	5
hcv specific cd t	5
positively correlated with the	5
for early diagnosis of	5
for hepatitis b surface	5
between the portal vein	5
of hepatic blood flow	5
diseases in patients with	5
occurs in approximately of	5
disorders of the liver	5
was associated with an	5
as a treatment for	5
patients infected with hcv	5
is considered as one	5
ill patients with sars	5
and mortality in covid	5
chronic liver failure in	5
of lipid nanoparticles for	5
treatment of acetaminophen toxicity	5
outcome of patients with	5
may not be possible	5
serum bile acids in	5
the young dog and	5
the results of this	5
were enrolled in the	5
analyzed by flow cytometry	5
is often found in	5
used to explore the	5
gene expression changes and	5
regulatory t cells in	5
etiology of liver disease	5
clotting times in clinically	5
t cell responses to	5
mechanism of action of	5
weeks after cessation of	5
prophylaxis of spontaneous bacterial	5
foals with liver disease	5
the absence of other	5
is dependent on the	5
fatty liver disease diagnostic	5
a series of patients	5
and feline liver diseases	5
important to remember that	5
be used for the	5
in order to evaluate	5
chronic liver insufficiency is	5
chronic hepatitis c were	5
and elevated liver enzymes	5
liver is the primary	5
than log copies ml	5
and liver transplant providers	5
acute liver failure induced	5
spontaneous bacterial peritonitis in	5
does not have a	5
during the dissection stage	5
to be the major	5
was an independent risk	5
the gastrointestinal tract and	5
carcinoma in patients with	5
the probability of survival	5
solid organ transplant recipients	5
the development of cirrhosis	5
with the novel coronavirus	5
of portal hypertension in	5
during the first two	5
there were no differences	5
patients with preexisting liver	5
the presence of pre	5
have been used in	5
a murine model of	5
in the immediate postoperative	5
disease in the dog	5
patients with corona virus	5
of which are tumour	5
of the th century	5
is metabolized by the	5
and multiple organ failure	5
condition of the patient	5
present study was designed	5
chronic liver disease patients	5
also been associated with	5
a screening test for	5
was significantly lower in	5
study was undertaken to	5
of patients with nafld	5
acute liver failure caused	5
histopathologic evaluation of the	5
therapy of liver failure	5
was added to the	5
signs of hepatic encephalopathy	5
none of the cases	5
the diagnosis of liver	5
and natural killer t	5
liver damage due to	5
is widely used in	5
than that of the	5
of a prospective study	5
of th and th	5
on histopathologic examination of	5
transplantation is the only	5
in this retrospective study	5
it is essential to	5
the one in the	5
were admitted to the	5
united network for organ	5
to the one in	5
one of the main	5
which is similar to	5
should be made to	5
in the size of	5
failure from other causes	5
in the severe group	5
the portal and systemic	5
and bleeding complications after	5
in most cases of	5
been found to be	5
definition and diagnostic criteria	5
or if there is	5
compared to patients with	5
with a prevalence of	5
measurement of serum bile	5
to be involved in	5
may be because of	5
patients with cirrhosis due	5
were measured before and	5
the liver and cytologic	5
the level of serum	5
should be used with	5
and the relationship between	5
patients with chb and	5
risk of infection and	5
or may not be	5
activity of serum liver	5
review of the literature	5
urine copper zinc ratio	5
serum level of alt	5
our understanding of the	5
the study is to	5
use of these supplements	5
the success rate of	5
for the use of	5
on the treatment of	5
to explore the risk	5
the author has found	5
associated with the progression	5
to the management of	5
on the underlying cause	5
common in cats with	5
were significantly lower in	5
within a few days	5
decreased in patients with	5
is not uncommon in	5
note springer nature remains	5
in clinically ill cats	5
been proposed as a	5
of cd t cells	5
disorders of the canine	5
steatohepatitis in patients with	5
the existence of a	5
with preexisting liver disease	5
of a congenital pss	5
well as a decrease	5
assessment of liver fibrosis	5
of portal hypertension and	5
in the induction of	5
shown in the table	5
hcv core protein expression	5
proteins invoked by vitamin	5
liver injury in dogs	5
development and validation of	5
puppies and kittens with	5
serum alt and ast	5
that the level of	5
chronic rather than acute	5
was more frequent in	5
in egf induced liver	5
included in the study	5
with a mean age	5
causes of death in	5
among patients with chronic	5
of hepatic encephalopathy and	5
in the gastrointestinal tract	5
of vascular endothelial growth	5
the presence of severe	5
polycystic kidney disease in	5
infection in severe hepatitis	5
is higher in severe	5
are listed in table	5
liver function tests and	5
of the study is	5
acute pancreatitis in cats	5
signs of gastrointestinal disease	5
in approximately of patients	5
basis of chronic liver	5
to cause clinical signs	5
clinical outcomes in patients	5
compared to healthy controls	5
egf induced liver cancer	5
with elevated liver enzymes	5
plays a crucial role	5
hepatic neoplasms in cats	5
has been implicated as	5
two to three times	5
severe enough to cause	5
vitamins a and d	5
history of chronic liver	5
characteristics and outcomes of	5
only a minority of	5
the time of surgery	5
among patients with liver	5
a result of hepatic	5
liver injury was defined	5
play a key role	5
a single center in	5
that there are no	5
shown to be an	5
these patients should be	5
most commonly associated with	5
hepatic fibrosis and cirrhosis	5
of the effect of	5
the immediate postoperative period	5
and the results of	5
for disease control and	5
enhancer ii basal core	5
is a combination of	5
multivariate analysis revealed that	5
in the postoperative period	5
log copies ml and	5
patients with hbv dna	5
a severe form of	5
in light of the	5
was to examine the	5
the development of portal	5
been described in a	5
thomas jefferson university hospital	5
ascites and hepatorenal syndrome	5
gene expression in the	5
fatty liver disease the	5
a low level of	5
specific gene expression changes	5
was significantly correlated with	5
the first month of	5
depending on the underlying	5
a novel coronavirus from	5
human hepatoma cell line	5
patients with cirrhosis of	5
fractionated plasma separation and	5
there has been no	5
subjects with chronic hepatitis	5
the results of our	5
mycobacterium avium infection in	5
system in patients with	5
to make a diagnosis	5
ii basal core promoter	5
the acute liver failure	5
patients with acute pancreatitis	5
can be increased by	5
acid concentrations in the	5
patients infected with the	5
at different stages of	5
acute fulminant liver failure	5
should be performed as	5
some studies demonstrated that	5
the location of the	5
a high risk of	5
resolution of clinical signs	5
american and english cocker	5
women from the mainland	5
even in the absence	5
the antioxidant activity of	5
were independent predictors of	5
these results demonstrate that	5
with and without t	5
serum liver enzyme activity	5
in patients with esld	5
of the liver are	5
paediatric acute liver failure	5
a large reserve capacity	5
a mean age of	5
patients with alcoholic cirrhosis	5
but it is important	5
clinical course and outcomes	5
is the major cause	5
of all patients with	5
of the risk of	5
the activity of the	5
plays a role in	5
patient and graft survival	5